LaBrosse Nicole

Halozyme Therapeutics, Inc. ยท SVP

LaBrosse Nicole is listed in public filings as officer: SVP, CHIEF FINANCIAL OFFICER. This LaBrosse Nicole insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO). Investors use LaBrosse Nicole's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Halozyme Therapeutics, Inc.HALO$2.7M38.5k sharesGrant / ExerciseFeb 23, 2026$254.9K3.6k shares$70.64--
Halozyme Therapeutics, Inc.HALO--36.4k sharesGrant / ExerciseFeb 23, 2026Disclosure amount unavailable6.7k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Halozyme Therapeutics, Inc.HALO$2.5M35.4k sharesGrant / ExerciseFeb 20, 2026$204.1K2.9k shares$70.98--
Halozyme Therapeutics, Inc.HALO--16k sharesGrant / ExerciseFeb 20, 2026Disclosure amount unavailable5.3k shares----
Halozyme Therapeutics, Inc.HALO$2.6M33k sharesGrant / ExerciseFeb 16, 2026$577.8K7.3k shares$79.44--
Halozyme Therapeutics, Inc.HALO$2.1M26.9k sharesGrant / ExerciseFeb 16, 2026$228.3K2.9k shares$79.44--
Halozyme Therapeutics, Inc.HALO$1.9M24.4k sharesGrant / ExerciseFeb 16, 2026$218.2K2.7k shares$79.44--
Halozyme Therapeutics, Inc.HALO--5.1k sharesGrant / ExerciseFeb 16, 2026Disclosure amount unavailable5.1k shares----
Halozyme Therapeutics, Inc.HALO--13.4k sharesGrant / ExerciseFeb 16, 2026Disclosure amount unavailable13.4k shares----
Halozyme Therapeutics, Inc.HALO--5.3k sharesGrant / ExerciseFeb 16, 2026Disclosure amount unavailable5.3k shares----
Halozyme Therapeutics, Inc.HALO--13.4k sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable5.2k shares----
Halozyme Therapeutics, Inc.HALO--29.5k sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable29.5k shares----
Halozyme Therapeutics, Inc.HALO--43k sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable7.4k shares----
Halozyme Therapeutics, Inc.HALO$1.7M22.4k sharesSellSep 22, 2025$148.9K1.9k shares$77.83--
Halozyme Therapeutics, Inc.HALO$1.7M22.1k sharesSellSep 22, 2025$24.7K314 shares$78.67--
Halozyme Therapeutics, Inc.HALO$1.8M24.3k sharesSellSep 10, 2025$1.0M13.2k shares$75.93--
Halozyme Therapeutics, Inc.HALO$2.8M37.5k sharesSellSep 10, 2025$509.0K6.8k shares$75.29--
Halozyme Therapeutics, Inc.HALO$011.3k sharesGrant / ExerciseSep 10, 2025$136.0K11.3k shares$12.07--
Halozyme Therapeutics, Inc.HALO$10k812 sharesGrant / ExerciseSep 10, 2025$14.2K1.1k shares$12.49--
Halozyme Therapeutics, Inc.HALO$1.8M31.9k sharesGrant / ExerciseFeb 23, 2025$208.0K3.6k shares$57.75--
Halozyme Therapeutics, Inc.HALO--20.1k sharesGrant / ExerciseFeb 23, 2025Disclosure amount unavailable6.7k shares----